Celcuity (CELC) EPS (Weighted Average and Diluted) (2022 - 2025)
Celcuity (CELC) reported EPS (Weighted Average and Diluted) of -$0.98 for Q4 2025, down 12.64% on a YoY basis from -$1.12 in Q4 2024, and down 6.52% quarter-over-quarter from -$0.92 in Q3 2025.
Celcuity (CELC) EPS (Weighted Average and Diluted) (2022 - 2025) Analysis & Trends
Celcuity has reported EPS (Weighted Average and Diluted) for 4 years, with the latest figure at -$0.98 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 12.64% year-over-year to -$0.98; the trailing twelve-month figure through Dec 2025 stood at -$3.8 (down 34.28% YoY), and the FY2025 full-year result was -$3.79, down 33.92% from the prior year.
- EPS (Weighted Average and Diluted) for Q4 2025 stood at -$0.98, down from -$0.92 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.55 in Q1 2023, with the low at -$1.04 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.76 across 4 years, with a median of -$0.7 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) gained 15.66% — and 2025, when it slumped 67.74%.
- Celcuity's EPS (Weighted Average and Diluted) stood at -$0.69 in 2022, then advanced by 7.25% to -$0.64 in 2023, then sank by 35.94% to -$0.87 in 2024, then declined by 12.64% to -$0.98 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.98 (Q4 2025), -$0.92 (Q3 2025), and -$1.04 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -0.92 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -0.86 |
| Dec 31, 2024 | -0.87 |
| Sep 30, 2024 | -0.70 |
| Jun 30, 2024 | -0.62 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -0.64 |
| Sep 30, 2023 | -0.83 |
| Jun 30, 2023 | -0.66 |
| Mar 31, 2023 | -0.55 |
| Dec 31, 2022 | -0.69 |
| Sep 30, 2022 | -0.75 |
| Jun 30, 2022 | -0.67 |